-
Mashup Score: 0Diabetes Dialogue: ADCES 2023 Recap - 1 year(s) ago
In this episode, which is the first of multiple special edition ADCES 2023 episodes, hosts hold an overarching discussion of the meeting itself and major themes from the ADCES’s 50th anniversary celebration.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
In this episode, hosts take time to break down the implications of two, potentially paradigm-shifting news in the announcement of the addition of bexagliflozin to the Cost Plus Drugs platform and topline data from the landmark SELECT trial.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Earlier this week, we launched the latest episode of #DiabetesDialogue. Hear from @DianaMIsaacs and @natalie_bellini on the latest developments in #diabetes management: https://t.co/dDzSF1i0ug https://t.co/Lf9uml89Q4
-
-
Mashup Score: 0
In this episode, hosts take time to break down the implications of two, potentially paradigm-shifting news in the announcement of the addition of bexagliflozin to the Cost Plus Drugs platform and topline data from the landmark SELECT trial.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
In the latest #DiabetesDialogue, @DianaMIsaacs and @natalie_bellini sit down for a discussion on the implications of bexagliflozin's addition to @costplusdrugs and SELECT results: https://t.co/uIXccnJqWW #Diabetes #Obesity https://t.co/4ete3VB32w
-
-
Mashup Score: 0
Julie Heverly, of the Time in Range Coalition, discusses the history of time in range, offers perspective on its utility as a glucose metric, and provides an overview of the efforts of the Time in Range Coalition to advance use and education around time in range.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Need a breakdown on the optimal role of time in range in the management of #diabetes? Check out this #DiabetesDialogue episode with @DianaMIsaacs and @natalie_bellini with Julie Heverly of @diaTribeNews from #ADA2023: https://t.co/q6W0ubKKDE https://t.co/i9mV7ek1XM
-
-
Mashup Score: 0
Julie Heverly, of the Time in Range Coalition, discusses the history of time in range, offers perspective on its utility as a glucose metric, and provides an overview of the efforts of the Time in Range Coalition to advance use and education around time in range.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Need a breakdown on the optimal role of time in range in the management of #diabetes? Check out this #DiabetesDialogue episode with @DianaMIsaacs and @natalie_bellini with Julie Heverly of @diaTribeNews from #ADA2023: https://t.co/q6W0ubKKDE https://t.co/ngufFJiX6e
-
-
Mashup Score: 0Diabetes Dialogue: ADA 2023 Recap - 1 year(s) ago
After a whirlwind conference packed with special episodes and late-breaking data, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss their top takeaways from ADA 2023.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Last week, @DianaMIsaacs and @natalie_bellini hosts of #DiabetesDialogue, sat down to record a recap of their top takeaways from #ADA2023. In this clip, Isaacs discusses data from orforglipron: https://t.co/sjQqijIk3S #Diabetes https://t.co/2cbfLCwAIk
-
-
Mashup Score: 0Diabetes Dialogue: ADA 2023 Recap - 1 year(s) ago
After a whirlwind conference packed with special episodes and late-breaking data, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss their top takeaways from ADA 2023.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Need a refresher on #ADA2023? #DiabetesDialogue hosts @DianaMIsaacs and @natalie_bellini have you covered in our recap episode. https://t.co/zGc6k4i8h3 https://t.co/AkcOwcQbWn
-
-
Mashup Score: 0
Hosts are joined by Gary Scheiner, MS, of Integrated Diabetes Services, to discuss the latest developments in diabetes technology from the floor of the 83rd Scientific Sessions of the American Diabetes Association.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In this episode of #DiabetesDialogue, hosts @DianaMIsaacs and @Natalie_Bellini are joined by Gary Scheiner, MS, of @Integ_Diabetes to discuss the latest developments in diabetes technology from the floor of #ADA2023. https://t.co/3eAOJuQkrx #Diabetes
-
-
Mashup Score: 0
Julie Heverly, of the Time in Range Coalition, discusses the history of time in range, offers perspective on its utility as a glucose metric, and provides an overview of the efforts of the Time in Range Coalition to advance use and education around time in range.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
The latest episode of #DiabetesDialogue is now live! Hear from Julie Heverly of the Time in Range Coalition as she sits down with hosts @DianaMIsaacs and @natalie_bellini from the floor at #ADA2023: https://t.co/xRfdbaE58P https://t.co/K60M2TnlX9
-
-
Mashup Score: 0Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO - 2 year(s) ago
Investigators from the TRANSITION-T2D study join Diabetes Dialogue to discuss the study and implications for care.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In the latest episode of #DiabetesDialogue our hosts sit down with Drs. Paloma Rodriguez and Kevin Pantalone to discuss the results of TRANSITION-T2D: https://t.co/lFUzTIBI76 #Diabetes
-
In this #DiabetesDialogue—the first of multiple special edition #ADCES2023 episodes—@DianaMIsaacs and @natalie_bellini hold a discussion of the meeting itself and major themes from the ADCES's 50th anniversary celebration: https://t.co/B5AiuBvhRh #Diabetes https://t.co/bT3AHZ07aR